GLOBAL MED (Germany) Performance
| 9PU Stock | EUR 1.18 0.04 3.51% |
On a scale of 0 to 100, GLOBAL MED holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 0.39, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, GLOBAL MED's returns are expected to increase less than the market. However, during the bear market, the loss of holding GLOBAL MED is expected to be smaller as well. Please check GLOBAL MED's treynor ratio, downside variance, and the relationship between the total risk alpha and value at risk , to make a quick decision on whether GLOBAL MED's current trending patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in GLOBAL MED SA are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, GLOBAL MED reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Dividend Yield | 0.0139 | |
| Payout Ratio | 0.6572 |
GLOBAL |
GLOBAL MED Relative Risk vs. Return Landscape
If you would invest 84.00 in GLOBAL MED SA on August 27, 2024 and sell it today you would earn a total of 34.00 from holding GLOBAL MED SA or generate 40.48% return on investment over 90 days. GLOBAL MED SA is currently producing 0.5859% returns and takes up 3.5735% volatility of returns over 90 trading days. Put another way, 31% of traded stocks are less volatile than GLOBAL, and 89% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
GLOBAL MED Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GLOBAL MED's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GLOBAL MED SA, and traders can use it to determine the average amount a GLOBAL MED's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.164
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 9PU | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.57 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.59 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average GLOBAL MED is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GLOBAL MED by adding it to a well-diversified portfolio.
GLOBAL MED Fundamentals Growth
GLOBAL Stock prices reflect investors' perceptions of the future prospects and financial health of GLOBAL MED, and GLOBAL MED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GLOBAL Stock performance.
| Return On Equity | 0.0183 | |||
| Return On Asset | 0.0111 | |||
| Profit Margin | 0.01 % | |||
| Shares Outstanding | 87.1 M | |||
| Debt To Equity | 0.28 % | |||
| Earnings Per Share | 0.01 X | |||
About GLOBAL MED Performance
By analyzing GLOBAL MED's fundamental ratios, stakeholders can gain valuable insights into GLOBAL MED's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if GLOBAL MED has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GLOBAL MED has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Global Cosmed S.A. produces, sells, and exports cosmetics and household chemicals in Poland and internationally. Global Cosmed S.A. was founded in 1990 and is headquartered in Radom, Poland. GLOBAL COSMED is traded on Frankfurt Stock Exchange in Germany.Things to note about GLOBAL MED SA performance evaluation
Checking the ongoing alerts about GLOBAL MED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GLOBAL MED SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GLOBAL MED SA may become a speculative penny stock | |
| GLOBAL MED SA appears to be risky and price may revert if volatility continues | |
| The company has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist GLOBAL MED until it has trouble settling it off, either with new capital or with free cash flow. So, GLOBAL MED's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like GLOBAL MED SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for GLOBAL to invest in growth at high rates of return. When we think about GLOBAL MED's use of debt, we should always consider it together with cash and equity. | |
| About 88.0% of the company shares are owned by insiders or employees |
- Analyzing GLOBAL MED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GLOBAL MED's stock is overvalued or undervalued compared to its peers.
- Examining GLOBAL MED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GLOBAL MED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of GLOBAL MED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GLOBAL MED's stock. These opinions can provide insight into GLOBAL MED's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for GLOBAL Stock analysis
When running GLOBAL MED's price analysis, check to measure GLOBAL MED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GLOBAL MED is operating at the current time. Most of GLOBAL MED's value examination focuses on studying past and present price action to predict the probability of GLOBAL MED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GLOBAL MED's price. Additionally, you may evaluate how the addition of GLOBAL MED to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |